Alnylam Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Period Progress
The Financial Results and More
Today, July 31, 2025, Alnylam Pharmaceuticals (ALNY) - the leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter ended June 30, 2025 and reviewed recent business highlights.
From Alnylam Pharmaceuticals
Yvonne Greenstreet, M.D., Chief Executive Officer of . . .
This content is for paid subscribers.
Today’s Highlights
July 31, 2025
